| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.84M | - | |
| Dir | 164.0K | $12.50M | -8,000 | |
| VP | 100.3K | $7.65M | - | |
| VP | 83.3K | $6.35M | -60,846 | |
| CFO | 82.7K | $6.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Wender Joseph H | Director | Sell | 28,000 | $80.82 | $2,262,847.67 | -26.0% | -0.0% | - | |
| Nov 25, 2025 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sale+OE | 16,777 | $80.91 | $1,357,442.17 | -49.0% | +4.5% | - | |
| Nov 25, 2025 | Klein Joseph III60 | Director | Sale+OE | 12,000 | $80.00 | $960,000.00 | -100% | +4.5% | - | |
| Nov 19, 2025 | Herman Joan E | Director | Sale+OE | 44,000 | $72.13 | $3,173,830.00 | -32.3% | +9.9% | - | |
| Nov 6, 2025 | Birchler Brian52 | EVP, Corp And Development Ops | Sell | 8,000 | $76.17 | $609,379.20 | -14.1% | +14.7% | - | |
| Nov 6, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 34,639 | $75.69 | $2,621,815.84 | -12.7% | +14.7% | - | |
| Nov 3, 2025 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 90,929 | $75.11 | $6,829,431.39 | -21.2% | +12.8% | - | |
| Oct 31, 2025 | Loscalzo Joseph | Director | Sale+OE | 16,000 | $75.10 | $1,201,668.80 | -30.6% | +12.9% | - | |
| Oct 31, 2025 | Wender Joseph H | Director | Sell | 28,000 | $74.02 | $2,072,577.59 | -8.3% | +12.9% | - | |
| Oct 16, 2025 | Swayze Eric63 | EVP Research | Sale+OE | 53 | $73.62 | $3,901.93 | -17.2% | +7.9% | - |